Tonix Pharmaceuticals Announces Collaboration with Boston Children’s Hospital

News
December 09, 2022•1 min read

Montana’s Tonix Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Boston Children’s Hospital to study TNX-15001 (Fc-modified anti-CD40L mAb) for the prevention of graft-versus-host disease (GvHD) after hematopoietic stem cell transplantation (HCT) in animals.

Montana BioScience Alliance is the statewide organization dedicated to advancing and advocating for Montana’s bioscience industry. The Alliance connects researchers, companies, and policymakers to strengthen research, support responsible policy, and drive economic growth across the state.

Montana BioScience Alliance

Montana BioScience Alliance is the statewide organization dedicated to advancing and advocating for Montana’s bioscience industry. The Alliance connects researchers, companies, and policymakers to strengthen research, support responsible policy, and drive economic growth across the state.

Back to Blog

Advancing a connected, competitive bioscience ecosystem for Montana’s people, communities, and economy.

Contact

Montana BioScience Alliance

PO Box 6464

Bozeman, MT 59771

+1 (406) 800-4409

Connect